Visit us for deeper explorations of the retina
Imagine Eyes is the leading pioneer in cellular-resolution retinal imaging.
rtx1 retinal camera | Reference AO device for clinical research and trials, proven by 250 publications. It reveals microscopic lesions and minute progressions through quick exams, and provides biomarkers for assessing photoreceptor, RPE and microvascular alterations.
For trial sponsors and CROs: Successfully implement AO biomarkers in studies and trials thanks to our services with global coverage.
m2OCT | Multimodal imaging enhanced with near-histological 3D resolution. SLO, OCT, OCTA, AOSLO, AOOCT and AOOCTA in a single device designed for clinical settings.
For developers of new technology: With custom m2 systems, AO modalities are ready for integration in your experimental ophthalmic setup, including for pre-clinical (animal) applications.
New at ARVO this year:
- rtx1 new features streamline the use of AO images in clinical studies and trials, and new imaging modes enable exploring new biomarkers.
- new m2OCT device delivers SLO, OCT and OCTA scans over large fields of view, as well as cellular-resolution images with AO-enhanced modalities.
Brands: Clinical research: rtx1 retinal camera, m2OCT.
Pre-clinical applications: custom m2 system, AOkit components (mirao, µDM, HASO, WaveTune).
Imaging modalities: flood, transscleral, SLO, SS-OCT, OCTA...